Istituto Dermopatico Dell'Immacolata-Istituto di Ricerca e Cura a Carattere Scientifico, Rome 00167, Italy.
Br J Dermatol. 2010 Mar;162(3):611-8. doi: 10.1111/j.1365-2133.2009.09576.x. Epub 2009 Nov 10.
Accurate assessment of the somatic mutational status of clonal immunoglobulin variable region (IgV) genes is relevant in elucidating tumour cell origin in B-cell lymphoma; virgin B cells bear unmutated IgV genes, while germinal centre and postfollicular B cells carry mutated IgV genes. Furthermore, biases in the IgV repertoire and distribution pattern of somatic mutations indicate a possible antigen role in the pathogenesis of B-cell malignancies.
This work investigates the cellular origin and antigenic selection in primary cutaneous B-cell lymphoma (PCBCL).
We analysed the nucleotide sequence of clonal IgV heavy-chain gene (IgVH) rearrangements in 51 cases of PCBCL (25 follicle centre, 19 marginal zone and seven diffuse large B-cell lymphoma, leg-type) and compared IgVH sequences with their closest germline segment in the GenBank database. Molecular data were then correlated with histopathological features.
We showed that all but one of the 51 IgVH sequences analysed exhibited extensive somatic hypermutations. The detected mutation rate ranged from 1.6% to 21%, with a median rate of 9.8% and was independent of PCBCL histotype. Calculation of antigen-selection pressure showed that 39% of the mutated IgVH genes displayed a number of replacement mutations and silent mutations in a pattern consistent with antigenic selection. Furthermore, two segments, VH1-69 (12%) and VH4-59 (14%), were preferentially used in our case series.
Data indicate that neoplastic B cells of PBCBL have experienced germinal centre reaction and also suggest that the involvement of IgVH genes is not entirely random in PCBCL and that common antigen epitopes could be pathologically relevant in cutaneous lymphomagenesis.
准确评估克隆免疫球蛋白可变区(IgV)基因的体细胞突变状态对于阐明 B 细胞淋巴瘤中的肿瘤细胞起源至关重要;原始 B 细胞携带未突变的 IgV 基因,而生发中心和滤泡后 B 细胞携带突变的 IgV 基因。此外,IgV 库的偏倚和体细胞突变的分布模式表明抗原可能在 B 细胞恶性肿瘤的发病机制中起作用。
本研究旨在探讨原发性皮肤 B 细胞淋巴瘤(PCBCL)中的细胞起源和抗原选择。
我们分析了 51 例 PCBCL(25 例滤泡中心、19 例边缘区和 7 例弥漫性大 B 细胞淋巴瘤,腿型)的克隆 IgV 重链基因(IgVH)重排的核苷酸序列,并将 IgVH 序列与 GenBank 数据库中最接近的种系片段进行比较。然后将分子数据与组织病理学特征相关联。
我们发现,在分析的 51 个 IgVH 序列中,除了一个序列外,其余序列均表现出广泛的体细胞超突变。检测到的突变率范围为 1.6%至 21%,中位数为 9.8%,与 PCBCL 组织类型无关。抗原选择压力的计算表明,39%的突变 IgVH 基因显示出数量的替代突变和沉默突变,模式与抗原选择一致。此外,我们的病例系列中优先使用了两个片段 VH1-69(12%)和 VH4-59(14%)。
数据表明,PBCBL 的肿瘤 B 细胞经历了生发中心反应,也表明 PCBCL 中 IgVH 基因的参与并非完全随机,常见的抗原表位可能与皮肤淋巴发生病理相关。